Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Diabetes Care|September 22, 2019
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled TrialSabine Kahl, Sofiya Gancheva, Klaus Straßburger, et al.Nature Communications|August 27, 2022
Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expressionMoh'd Mohanad Al-Dabet, Khurrum Shahzad, Ahmed Elwakiel, et al.Nature Communications|September 11, 2024
Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney diseaseAhmed Elwakiel, Dheerendra Gupta, Rajiv Rana, et al.The Lancet. Diabetes & Endocrinology|July 27, 2019
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up studyOana P Zaharia, Klaus Strassburger, Alexander Strom, et al.Diabetes|September 17, 2021
Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS)Andreas Fritsche, Robert Wagner, Martin Heni, et al.The EMBO Journal|October 7, 2024
TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemiaJenny Bröker-Lai, José Rego Terol, Christin Richter, et al.Nature Medicine|September 30, 2025
Prevention of type 2 diabetes through prediabetes remission without weight lossArvid Sandforth, Elsa Vazquez Arreola, Robert L Hanson, et al.The Lancet. Diabetes & Endocrinology|September 28, 2023
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, et al.Pageof 9